Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Ardent Health, Inc. (ARDT : NYSE)
 
 • Company Description   
Ardent Health Partners Inc. is a provider of healthcare. Ardent Health Partners Inc., formerly known as ARDENT HEALTH, is based in BRENTWOOD, Tenn.

Number of Employees: 24,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $9.39 Daily Weekly Monthly
20 Day Moving Average: 432,221 shares
Shares Outstanding: 143.19 (millions)
Market Capitalization: $1,344.53 (millions)
Beta: 0.45
52 Week High: $15.55
52 Week Low: $8.07
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 14.93% 15.94%
12 Week 6.83% 6.69%
Year To Date 6.34% 5.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
340 SEVEN SPRINGS WAY SUITE 100
-
BRENTWOOD,TN 37027
USA		 ph: 615-296-3000
fax: -		 investor.relations@ardenthealth.com http://www.ardenthealth.com
 
 • General Corporate Information   
Officers
Martin J. Bonick - President and Chief Executive Officer; Director
Alfred Lumsdaine - Chief Financial Officer
David Byers - Senior Vice President; Chief Accounting Officer
Mark Sotir - Director
Peter Bulgarelli - Director

Peer Information
Ardent Health, Inc. (CHCR)
Ardent Health, Inc. (ESRX)
Ardent Health, Inc. (MYDP)
Ardent Health, Inc. (COR)
Ardent Health, Inc. (GBCS)
Ardent Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 03980N107
SIC: 8062
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 03/04/26
Share - Related Items
Shares Outstanding: 143.19
Most Recent Split Date: (:1)
Beta: 0.45
Market Capitalization: $1,344.53 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.26 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.46 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 1.24% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 6.41
Trailing 12 Months: 4.39
PEG Ratio: 5.17
Price Ratios
Price/Book: 0.82
Price/Cash Flow: 3.70
Price / Sales: 0.21
EPS Growth
vs. Year Ago Period: 173.68%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 8.75%
vs. Previous Quarter: -4.17%
ROE
12/31/25 - -
09/30/25 - 19.02
06/30/25 - 16.66
ROA
12/31/25 - -
09/30/25 - 6.04
06/30/25 - 5.18
Current Ratio
12/31/25 - -
09/30/25 - 2.08
06/30/25 - 2.13
Quick Ratio
12/31/25 - -
09/30/25 - 1.95
06/30/25 - 2.00
Operating Margin
12/31/25 - -
09/30/25 - 4.79
06/30/25 - 4.11
Net Margin
12/31/25 - -
09/30/25 - 3.24
06/30/25 - 4.11
Pre-Tax Margin
12/31/25 - -
09/30/25 - 5.71
06/30/25 - 6.78
Book Value
12/31/25 - -
09/30/25 - 11.41
06/30/25 - 11.52
Inventory Turnover
12/31/25 - -
09/30/25 - 0.00
06/30/25 - 0.00
Debt-to-Equity
12/31/25 - -
09/30/25 - 0.67
06/30/25 - 0.66
Debt-to-Capital
12/31/25 - -
09/30/25 - 39.93
06/30/25 - 39.78
 

Powered by Zacks Investment Research ©